Fuhe Beihua Fang for Postoperative Syndrome of 40 Patients with Primary Liver Cancer after Intervention

OBJECTIVE To observe the clinical effects of Fuhe Beihua Fang on postoperative syndrome of 40 patients with primary liver cancer after interventional therapy. METHODS 80 cases were randomly divided two groups: control group and treatment group with 40 cases in each. Treatment group was given Fuhe Beihua Fang after undergoing hepatic artery chemotherapeutic embolism (TACE); while control group didn't. Then we observed integration changes of symptoms before and after treatment， and indexes of liver function (including alkaline phosphatase， AST and ALT)， Karnofsky score and change of tumor marker AFP. RESULTS Treatment group showed better effects on fever， nausea and vomiting， abdominal distension， jaundice and hypochondriac pain， compared with control group (P<0.05)， significantly improved patients' life quality (P<0.05)， relieved impairment of liver function(P<0.05) and lower ed AFP(P<0.05). CONCLUSION Fuhe Beihua Fang can effectively improve clinical symptoms of patients， lower tumor marker AFP caused by carcinoma， improve indexes of liver function and life quality of patients.